Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses

Paediatric Anaesthesia

Volumn 23, Issue 9, 2013, Pages 824-833

  Bandschapp, Oliver ^a   Iaizzo, Paul A ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

anesthetic considerations; hyperkalemic and hypokalemic periodic paralysis; myotonia congenita

Indexed keywords

1,4 DIHYDROPYRIDINE RECEPTOR; ACETYLCHOLINE; NICOTINIC RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED CHLORIDE CHANNEL; VOLTAGE GATED SODIUM CHANNEL;

ANESTHESIA; CALCIUM CHANNELOPATHY; CHLORIDE CHANNELOPATHY; CLINICAL FEATURE; EXCITATION CONTRACTION COUPLING; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; MUSCLE ACTION POTENTIAL; MUSCLE FIBER MEMBRANE; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PRIORITY JOURNAL; REVIEW; SARCOLEMMA; SKELETAL MUSCLE; SODIUM CHANNELOPATHY; THOMSEN DISEASE;

ANESTHETIC CONSIDERATIONS; HYPERKALEMIC AND HYPOKALEMIC PERIODIC PARALYSIS; MYOTONIA CONGENITA;

ANESTHESIA; CHANNELOPATHIES; HUMANS; HYPOKALEMIA; MUSCLE, SKELETAL; MYOTONIA CONGENITA; PARALYSES, FAMILIAL PERIODIC; PATIENT CARE PLANNING; SARCOLEMMA;

EID: 84881554279     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/pan.12217     Document Type: Review

References (93)

1. Allen DG, Lamb GD, Westerblad H,. Skeletal muscle fatigue: cellular mechanisms. Physiol Rev 2008; 88: 287-332.
2. Parness J, Bandschapp O, Girard T,. The myotonias and susceptibility to malignant hyperthermia. Anesth Analg 2009; 109: 1054-1064.
3. Iaizzo PA, Lehmann-Horn F,. The correlation between electrical after-activity and slowed relaxation in myotonia. Muscle Nerve 1990; 13: 240-246.
4. Rudel R, Lehmann-Horn F,. Membrane changes in cells from myotonia patients. Physiol Rev 1985; 65: 310-356.
5. Hodgkin AL, Horowicz P,. The influence of potassium and chloride ions on the membrane potential of single muscle fibres. J Physiol 1959; 148: 127-160.
6. Ruff RL,. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol Scand 1996; 156: 159-168.
7. Sjogaard G,. Exercise-induced muscle fatigue: the significance of potassium. Acta Physiol Scand Suppl 1990; 593: 1-63.
8. Jones DA,. High-and low-frequency fatigue revisited. Acta Physiol Scand 1996; 156: 265-270.
9. Westerblad H, Lee JA, Lannergren J, et al,. Cellular mechanisms of fatigue in skeletal muscle. Am J Physiol 1991; 261: C195-C209.
10. Pedersen TH, Nielsen OB, Lamb GD, et al,. Intracellular acidosis enhances the excitability of working muscle. Science 2004; 305: 1144-1147.
11. Bandschapp O, Soule CL, Iaizzo PA,. Lactic acid restores skeletal muscle force in an in vitro fatigue model: are voltage-gated chloride channels involved? Am J Physiol Cell Physiol 2012; 302: C1019-C1025.
12. Bennetts B, Rychkov GY, Ng HL, et al,. Cytoplasmic atp-sensing domains regulate gating of skeletal muscle clc-1 chloride channels. J Biol Chem 2005; 280: 32452-32458.
13. Ricker K, Moxley RT III, Heine R, Lehmann-Horn F,. Myotonia fluctuans. A third type of muscle sodium channel disease. Arch Neurol 1994; 51: 1095-1102.
14. Lehmann-Horn F, Kuther G, Ricker K, et al,. Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular ph. Muscle Nerve 1987; 10: 363-374.
15. Lehmann-Horn F, Rudel R, Ricker K,. Membrane defects in paramyotonia congenita (eulenburg). Muscle Nerve 1987; 10: 633-641.
16. Fontaine B, Khurana TS, Hoffman EP, et al,. Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 1990; 250: 1000-1002.
17. Ptacek LJ, George AL Jr, Griggs RC, et al,. Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991; 67: 1021-1027.
18. Ptacek LJ, George AL Jr, Barchi RL, et al,. Mutations in an s4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 1992; 8: 891-897.
19. Lehmann-Horn F, Jurkat-Rott K,. Voltage-gated ion channels and hereditary disease. Physiol Rev 1999; 79: 1317-1372.
20. Cannon SC, Brown RH Jr, Corey DP,. Theoretical reconstruction of myotonia and paralysis caused by incomplete inactivation of sodium channels. Biophys J 1993; 65: 270-288.
21. Raja Rayan DL, Hanna MG,. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol 2010; 23: 466-476.
22. Burge JA, Hanna MG,. Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep 2012; 12: 62-69.
23. Matthews E, Labrum R, Sweeney MG, et al,. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis. Neurology 2009; 72: 1544-1547.
24. Francis DG, Rybalchenko V, Struyk A, et al,. Leaky sodium channels from voltage sensor mutations in periodic paralysis, but not paramyotonia. Neurology 2011; 76: 1635-1641.
25. Jurkat-Rott K, Lehmann-Horn F,. State of the art in hereditary muscle channelopathies. Acta Myol 2010; 29: 343-350.
26. Pusch M,. Myotonia caused by mutations in the muscle chloride channel gene clcn1. Hum Mutat 2002; 19: 423-434.
27. George AL Jr, Crackower MA, Abdalla JA, et al,. Molecular basis of thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 1993; 3: 305-310.
28. Koch MC, Steinmeyer K, Lorenz C, et al,. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992; 257: 797-800.
29. Matthews E, Fialho D, Tan SV, et al,. The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. Brain 2010; 133: 9-22.
30. Farbu E, Softeland E, Bindoff LA,. Anaesthetic complications associated with myotonia congenita: case study and comparison with other myotonic disorders. Acta Anaesthesiol Scand 2003; 47: 630-634.
31. Lossin C, George AL Jr,. Myotonia congenita. Adv Genet 2008; 63: 25-55.
32. Winters JL, McLaughlin LA,. Myotonia congenita. A review of four cases. J Bone Joint Surg Am 1970; 52: 1345-1350.
33. Mitchell MM, Ali HH, Savarese JJ,. Myotonia and neuromuscular blocking agents. Anesthesiology 1978; 49: 44-48.
34. Looi I, Bakar AA, Lim CH, et al,. Anaesthetists' nightmare: masseter spasm after induction in an undiagnosed case of myotonia congenita. Med J Malaysia 2008; 63: 423-425.
35. Paterson IS,. Generalized myotonia following suxamethonium. A case report. Br J Anaesth 1962; 34: 340-342.
36. Heiman-Patterson T, Martino C, Rosenberg H, et al,. Malignant hyperthermia in myotonia congenita. Neurology 1988; 38: 810-812.
37. Russell SH, Hirsch NP,. Anaesthesia and myotonia. Br J Anaesth 1994; 72: 210-216.
38. Buzello W, Krieg N, Schlickewei A,. Hazards of neostigmine in patients with neuromuscular disorders. Report of two cases. Br J Anaesth 1982; 54: 529-534.
39. Galvez Canellas JL, Errando CL, Ordonez Arana A, et al,. Sugammadex, efficacious in reversing a neuromuscular block in a woman with becker muscular dystrophy. Rev Esp Anestesiol Reanim 2011; 58: 614-617.
40. de Boer HD, van Esmond J, Booij LH, et al,. Reversal of rocuronium-induced profound neuromuscular block by sugammadex in duchenne muscular dystrophy. Pediatr Anesth 2009; 19: 1226-1228.
41. Bandschapp O, Ginz HF, Soule CL, et al,. In vitro effects of propofol and volatile agents on pharmacologically induced chloride channel myotonia. Anesthesiology 2009; 111: 584-590.
42. Haeseler G, Stormer M, Bufler J, et al,. Propofol blocks human skeletal muscle sodium channels in a voltage-dependent manner. Anesth Analg 2001; 92: 1192-1198.
43. Haeseler G, Karst M, Foadi N, et al,. High-affinity blockade of voltage-operated skeletal muscle and neuronal sodium channels by halogenated propofol analogues. Br J Pharmacol 2008; 155: 265-275.
44. Cooper TA,. A reversal of misfortune for myotonic dystrophy? N Engl J Med 2006; 355: 1825-1827.
45. Hayashida S, Yanagi F, Tashiro M, et al,. Anesthetic managements of a patient with congenital myotonia (becker type). Masui 2004; 53: 1293-1296.
46. Conravey A, Santana-Gould L,. Myotonia congenita and myotonic dystrophy: surveillance and management. Curr Treat Options Neurol 2010; 12: 16-28.
47. Zanette G, Facco E, Micaglio M, et al,. Myotonia congenita and regional anaesthesia with peripheral nerve stimulation: a case report. Minerva Anestesiol 2007; 73: 529-531.
48. Mayhew JF, Moreno L,. Hyperthermia following anesthesia in a child with undiagnosed myotonia. Anaesthesiol Rev 1987; 24: 47-49.
49. Haberer JP, Fabre F, Rose E,. Malignant hyperthermia and myotonia congenita (thomsen's disease). Anaesthesia 1989; 44: 166.
50. Ptacek LJ, Johnson KJ, Griggs RC,. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993; 328: 482-489.
51. Koch MC, Ricker K, Otto M, et al,. Confirmation of linkage of hyperkalemic periodic paralysis to chromosome 17. J Med Genet 1991; 28: 583-586.
52. Lehmann-Horn F, Jurkat-Rott K, Rudel R,. Periodic paralysis: understanding channelopathies. Curr Neurol Neurosci Rep 2002; 2: 61-69.
53. Ptacek LJ, Tyler F, Trimmer JS, et al,. Analysis in a large hyperkalemic periodic paralysis pedigree supports tight linkage to a sodium channel locus. Am J Hum Genet 1991; 49: 378-382.
54. Lisak RP, Lebeau J, Tucker SH, et al,. Hyperkalemic periodic paralysis and cardiac arrhythmia. Neurology 1972; 22: 810-815.
55. Yoshimura T, Kaneuji M, Okuno T, et al,. Periodic paralysis with cardiac arrhythmia. Eur J Paediatr 1983; 140: 338-343.
56. Ashwood EM, Russell WJ, Burrow DD,. Hyperkalemic periodic paralysis and anaesthesia. Anaesthesia 1992; 47: 579-584.
57. Martyn JA, Richtsfeld M,. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-169.
58. Aarons JJ, Moon RE, Camporesi EM,. General anesthesia and hyperkalemic periodic paralysis. Anesthesiology 1989; 71: 303-304.
59. Lehmann-Horn F, Rüdel R, Jurkat-Rott K,. Nondystrophic Myotonias and Periodic Paralyses. New York: McGraw-Hill, 2004.
60. Depoix JP, Julliard JM, Aubry P,. Propofol-remifentanil target-controlled anesthesia in a patient with hyperkalemic familial periodic paralysis. Anesth Analg 2004; 99: 302.
61. Thiel A, Wagner M, Behr R, et al,. Anesthesia in familial hyperkalemic periodic paralysis. Anaesthesiol Intensivmed Notfallmed Schmerzther 1993; 28: 125-127.
62. Weller JF, Elliott RA, Pronovost PJ,. Spinal anesthesia for a patient with familial hyperkalemic periodic paralysis. Anesthesiology 2002; 97: 259-260.
63. Aouad R, Atanassoff PG,. Epidural anesthesia in a patient with hyperkalemic periodic paralysis undergoing orthopedic surgery. Can J Anaesth 2004; 51: 92.
64. Mackenzie MJ, Pickering E, Yentis SM,. Anaesthetic management of labour and caesarean delivery of a patient with hyperkalemic periodic paralysis. Int J Obstet Anesth 2006; 15: 329-331.
65. Barker MC,. Combined spinal/general anesthesia with postoperative femoral nerve block for total knee replacement in a patient with familial hyperkalemic periodic paralysis: a case report. AANA J 2010; 78: 191-194.
66. Ptacek LJ, Trimmer JS, Agnew WS, et al,. Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus. Am J Hum Genet 1991; 49: 851-854.
67. Ptacek LJ, Gouw L, Kwiecinski H, et al,. Sodium channel mutations in paramyotonia congenita and hyperkalemic periodic paralysis. Ann Neurol 1993; 33: 300-307.
68. McClatchey AI, Trofatter J, McKenna-Yasek D, et al,. Dinucleotide repeat polymorphisms at the scn4a locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am J Hum Genet 1992; 50: 896-901.
69. Heatwole CR, Statland JM, Logigian EL,. The diagnosis and treatment of myotonic disorders. Muscle Nerve 2013; 47: 632-648.
70. Streib EW,. Paramyotonia congenita. Semin Neurol 1991; 11: 249-257.
71. Kaneda T, Iwahashi M, Suzuki T,. Anesthetic management for subtotal gastrectomy in a patient with paramyotonia congenita. J Anesth 2007; 21: 500-503.
72. Ay B, Gercek A, Dogan VI, et al,. Pyloromyotomy in a patient with paramyotonia congenita. Anesth Analg 2004; 98: 68-69, table of contents.
73. Grace RF, Roach VJ,. Caesarean section in a patient with paramyotonia congenita. Anaesth Intensive Care 1999; 27: 534-537.
74. Howell PR, Douglas MJ,. Lupus anticoagulant, paramyotonia congenita and pregnancy. Can J Anaesth 1992; 39: 992-996.
75. Lambert C, Blanloeil Y, Horber RK, et al,. Malignant hyperthermia in a patient with hypokalemic periodic paralysis. Anesth Analg 1994; 79: 1012-1014.
76. Fontaine B, Vale-Santos J, Jurkat-Rott K, et al,. Mapping of the hypokalaemic periodic paralysis (hypopp) locus to chromosome 1q31-32 in three european families. Nat Genet 1994; 6: 267-272.
77. Rollman JE, Dickson CM,. Anesthetic management of a patient with hypokalemic familial periodic paralysis for coronary artery bypass surgery. Anesthesiology 1985; 63: 526-527.
78. 2+ channel expressed in xenopus laevis oocytes. J Physiol 1999; 520 (Pt 2): 321-336.
79. Bashford AC,. Case report: anaesthesia in familial hypokalaemic periodic paralysis. Anaesth Intensive Care 1977; 5: 74-75.
80. Siler JN, Discavage WJ,. Anesthetic management of hypokalemic periodic paralysis. Anesthesiology 1975; 43: 489-490.
81. Neuman GG, Kopman AF,. Dyskalemic periodic paralysis and myotonia. Anesth Analg 1993; 76: 426-428.
82. Marchant CL, Ellis FR, Halsall PJ, et al,. Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia. Muscle Nerve 2004; 30: 114-117.
83. Hofer C, Zalunardo MP, Zollinger A,. Total intravenous anaesthesia in a patient with familial hypokalaemic periodic paralysis. Anaesthesia 2001; 56: 1082-1085.
84. Lema G, Urzua J, Moran S, et al,. Successful anesthetic management of a patient with hypokalemic familial periodic paralysis undergoing cardiac surgery. Anesthesiology 1991; 74: 373-375.
85. Melnick B, Chang JL, Larson CE, et al,. Hypokalemic familial periodic paralysis. Anesthesiology 1983; 58: 263-265.
86. Chitra S, Korula G,. Anaesthetic management of a patient with hypokalemic periodic paralysis- a case report. Indian J Anaesth 2009; 53: 226-229.
87. Rooney RT, Shanahan EC, Sun T, et al,. Atracurium and hypokalemic familial periodic paralysis. Anesth Analg 1988; 67: 782-783.
88. Laurito CE, Becker GL, Miller PE,. Atracurium use in a patient with familial periodic paralysis. J Clin Anesth 1991; 3: 225-228.
89. Maciel RM, Lindsey SC, Dias da Silva MR,. Novel etiopathophysiological aspects of thyrotoxic periodic paralysis. Nat Rev Endocrinol 2011; 7: 657-667.
90. Ryan DP, da Silva MR, Soong TW, et al,. Mutations in potassium channel kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis. Cell 2010; 140: 88-98.
91. Wong GW, Leung TF, Lo AF, et al,. Thyrotoxic periodic paralysis in a 14-year-old boy. Eur J Pediatr 2000; 159: 934.
92. Diedrich DA, Wedel DJ,. Thyrotoxic periodic paralysis and anesthesia report of a case and literature review. J Clin Anesth 2006; 18: 286-292.
93. Pusch M,. Chloride Movements Across Cellular Membranes. London: Elsevier, 2007.